Drug Review (drug + review)

Distribution by Scientific Domains


Selected Abstracts


ACE inhibitors: their propertiesand current role in hypertension

PRESCRIBER, Issue 14 2009
Sze-Yuan Ooi MB BS
ACE inhibitors remain the first-line choice of treatment of hypertension in patients under 55 years, and second line in other patient groups. Our Drug Review considers their properties and the latest evidence for their use in hypertension, followed by further sources of information and an analysis of prescription data. Copyright © 2009 Wiley Interface Ltd. [source]


Insomnia: guide to diagnosis and choice of treatment

PRESCRIBER, Issue 8 2008
Sue Wilson PhD
The tiredness and poor performance associated with insomnia have a considerable impact on quality of life. Our Drug Review considers when drug treatments are justified and which are preferred, followed by sources of further information and a review of prescription data. Copyright © 2008 Wiley Interface Ltd [source]


Diagnosis and medical management of endometriosis

PRESCRIBER, Issue 24 2006
Alex Swanton MRCOG
The choice of treatment in endometriosis is dictated by symptom severity and whether the patient wishes to conceive. Our Drug Review describes the surgical diagnosis and medical and surgical treatment options, followed by sources of further information and the Datafile. Copyright © 2006 Wiley Interface Ltd [source]


Current management of inflammatory bowel disease

PRESCRIBER, Issue 22 2006
Sally Parry MD
Inflammatory bowel disease is a common disorder that affects young and old and has great impact on the lives of those affected. Our Drug Review discusses the properties and recommended use of the treatments currently available, followed by sources of further information, an analysis of prescription data and the Datafile. Copyright © 2006 Wiley Interface Ltd [source]


Primary care management of bacterial skin infections

PRESCRIBER, Issue 16 2006
Una Ni Riain MRCPath
Bacterial skin infections are commonly seen in primary care and can usually be successfully managed with topical or systemic anti-biotics. Our Drug Review discusses their recommended treatment, followed by sources of further information and the Datafile. Copyright © 2006 Wiley Interface Ltd [source]


Lipid-lowering treatment: today's recommended management

PRESCRIBER, Issue 10 2006
Jane Armitage MRCP
Lipid-lowering therapy is now recommended for nearly all patients at increased cardiovascular risk regardless of their cholesterol level. Our Drug Review discusses the efficacy and adverse effects of the various lipid-lowering therapies, followed by sources of further information, an analysis of prescription data and the Datafile. Copyright © 2006 Wiley Interface Ltd [source]


Going for Gold, from Beijing to Munich, Highlights from the ESC 2008 Congress: BEAUTIFUL, GISSI-HF, and Potential New Therapies for Acute Decompensated Heart Failure

CARDIOVASCULAR THERAPEUTICS, Issue 4 2008
Paul Kalra
Formerly Cardiovascular Drug Reviews http://www.blackwellpublishing.com/CATH [source]


Guide to properties and efficacy of drugs used in migraine

PRESCRIBER, Issue 17 2010
Manuela Fontebasso MB ChB
It is essential to devise an individualised treatment plan in the management of migraine. Our Drug review considers the properties and efficacy of the various drugs used in treatment and prevention, followed by an analysis of prescription data and sources of further information. Copyright © 2010 Wiley Interface Ltd [source]


Evaluation and recommended treatment of anaemia

PRESCRIBER, Issue 12 2010
Alastair Smith FRCP, FRCPath
The management of anaemia first requires an evaluation of the underlying cause of the disorder. Our Drug review considers the various oral and parenteral treatments available, followed by an analysis of prescription data and sources of further information. Copyright © 2010 Wiley Interface Ltd [source]


Treatment options in chronic obstructive pulmonary disease

PRESCRIBER, Issue 8 2010
Paul Walker BMedSci
Management of chronic obstructive pulmonary disease requires a true multidisciplinary approach, and therapies with a strong evidence base can bring benefits to patients. Our Drug review considers the available treatments and their efficacy, followed by sources of further information. Copyright © 2010 Wiley Interface Ltd [source]


Antibiotics for uncomplicated urinary tract infection in women

PRESCRIBER, Issue 7 2010
MB ChB, Sarah Thompson BSc
Most well women with uncomplicated urinary tract infection should respond to three days' treatment with a first-line antibiotic. Our Drug review describes the properties and side-effects of the recommended antibiotics, followed by sources of further information. Copyright © 2010 Wiley Interface Ltd [source]


Current treatment options in the management of severe pain

PRESCRIBER, Issue 6 2010
FFARCSI, FFPMRCA, William Campbell MD
Opioids are the most frequently used agents for severe nociceptive pain and should not be withheld in chronic noncancer pain. Our Drug review discusses the properties and efficacy of the opioids in common use, followed by an analysis of the prescription data and sources of further information. Copyright © 2010 Wiley Interface Ltd [source]


Drugs in type 2 diabetes: their properties and recommended use

PRESCRIBER, Issue 5 2010
Ian Campbell FRCP
There are now six classes of oral antidiabetic drugs and a new class of injectable GLP-1 agonists in the drug therapy of type 2 diabetes, with metformin remaining the cornerstone of treatment. Our Drug review considers their mode of action, properties and recommended use, followed by sources of further information and an analysis of prescription data. Copyright © 2010 Wiley Interface Ltd [source]


Nongenital warts: clinical features and recommended treatment

PRESCRIBER, Issue 22 2009
Fawad Hussain MRCP
Viral warts are one of the most common cutaneous diseases, and treatment can be difficult and frustrating with frequent failures. In our Drug review we discuss the clinical presentations and treatment options, followed by sources of further information. Copyright © 2009 Wiley Interface Ltd [source]


Acne: guide to features and recommended management

PRESCRIBER, Issue 15-16 2009
Edward Seaton MA
Acne typically presents during puberty and can cause significant psychological morbidity and facial scaring. Our Drug review describes the underlying aetiology of acne development and the available treatments, followed by a review of the prescription data and sources of further information. Copyright © 2009 Wiley Interface Ltd [source]


Glaucoma: target intraocular pressures and current treatments

PRESCRIBER, Issue 7 2009
FRCOphth, James McAllister FRCS
Our Drug review of glaucoma management describes the use of target intraocular pressures in directing treatment, and the medical, laser and surgical management options. This is followed by an analysis of prescription data and sources of further information. Copyright © 2009 Wiley Interface Ltd [source]


Depression: current approaches to management in primary care

PRESCRIBER, Issue 4 2009
Ian Reid PhD, MRCPsych
Our Drug review describes current prescribing guidelines and the properties of the antidepressant drugs available and discusses recent controversies surrounding antidepressant use. This is followed by further sources of information in Resources and an analysis of prescription data. Copyright © 2009 Wiley Interface Ltd [source]


Evidence-based drug treatment of chronic heart failure

PRESCRIBER, Issue 3 2009
Iain Squire MD
A wide range of drugs to treat heart failure is available, and an evidence-based approach to management is now possible. Our Drug review discusses the properties and side-effects of the various drug groups, followed by sources of further information. Copyright © 2009 Wiley Interface Ltd [source]


Recommended management of lower respiratory tract infections

PRESCRIBER, Issue 18 2008
DTM&H, MRCPath, Sarah Meisner PhD
Lower respiratory tract infections comprise a wide range of pathologies and causative pathogens that require differentiating in order to administer the most appropriate treatment. Our Drug review discusses the current recommended management of LRTIs in the community, followed by sources of further information in Resources. Copyright © 2008 Wiley Interface Ltd [source]


Current drug therapies for the secondary prevention of MI

PRESCRIBER, Issue 1 2008
Ninian Lang BSc(Hons)
Current approaches to the secondary prevention of myocardial infarction include the use of both well-established and newer agents. Our Drug review considers their mode of action and properties and the evidence base for their efficacy, followed by sources of further information and the Datafile. Copyright © 2008 Wiley Interface Ltd [source]


Current drug treatments for female urinary incontinence

PRESCRIBER, Issue 23 2006
Tarang Majmudar MRCOG
Several new drug treatments are now marketed for incontinence with improved efficacy and reduced side-effects. Our Drug review discusses the range of drugs currently available to treat this condition, followed by a review of prescription data, sources of further information and the Datafile. Copyright © 2006 Wiley Interface Ltd [source]


Appropriate drug treatment of mild-to-moderate pain

PRESCRIBER, Issue 18 2006
DPMed (CARCSI), FFARCSI, William Campbell MD
In this Drug review on the management of mild-to-moderate nociceptive pain, the author discusses the properties of the analgesics available and their efficacy, side-effects and interactions. This is followed by a review of prescription data, further sources of information and the Datafile. Copyright © 2006 Wiley Interface Ltd [source]


Diagnosis and management of helminth infections

PRESCRIBER, Issue 15 2006
DTM&H, William Newsholme MSc
A number of worm infections are seen in the UK, mostly acquired through foreign travel or found in immigrants. Our Drug review discusses currently recommended treatments, followed by sources of further information and a Datafile of licensed drugs. Copyright © 2006 Wiley Interface Ltd [source]


Current drug management of BPH in primary care

PRESCRIBER, Issue 14 2006
Claire Taylor MRCS
The range of drug treatments for BPH, alone and in combination, allow many patients to be managed in primary care and delay the need for referral. Our Drug review considers their efficacy and side-effects, followed by sources of further information, an analysis of prescription data and the Datafile. Copyright © 2006 Wiley Interface Ltd [source]


Current drug management of chronic heart failure

PRESCRIBER, Issue 12 2006
Iain Squire MD
For most patients with heart failure, treatment will now include a diuretic, an ACE inhibitor or angiotensin-II inhibitor and a beta-blocker. Our Drug review discusses the properties and side-effects of the wide range of drugs available, followed by sources of further information and the Datafile. Copyright © 2006 Wiley Interface Ltd [source]


Current management options for upper respiratory tract infection

PRESCRIBER, Issue 1 2006
MRCPath, Nilangi Virgincar MSc
Our Drug review discusses the diagnosis and current recommended management of common URTIs, followed by sources of further information and the Datafile. Copyright © 2006 Wiley Interface Ltd [source]